Hopefully the reason tat is not widely used is because it is not the best and maybe our fpp will get the scientists interested when they become aware that we can actually penetrate a high proportion of targetted cells rarher than just a small percentage. Still hopefully one succesful trial delivering a practical payload and interest might explode.
- Forums
- ASX - By Stock
- Ann: Fourfold Delivery Improvement in a New Lead Candidate
PYC
pyc therapeutics limited
Add to My Watchlist
3.33%
!
$1.24

Hopefully the reason tat is not widely used is because it is not...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M |
Open | High | Low | Value | Volume |
$1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 204320 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 4333 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 204320 | 1.240 |
1 | 1000 | 1.180 |
1 | 8000 | 1.135 |
1 | 2000 | 1.120 |
1 | 8968 | 1.115 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 4333 | 2 |
1.290 | 756 | 1 |
1.300 | 8000 | 1 |
1.320 | 2800 | 1 |
1.330 | 10000 | 1 |
Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |